Recruiting participants for new research studies can be challenging: those approached are often skeptical, concerned about side effects or unsure about benefits. However, phones have been ringing off the hook from people who want to gain entry to a new study examining the life-extension properties of metformin, a medication for Type 2 Diabetes. Researchers want to investigate whether this drug can be used more generally to slow down aging and prevent aging-related disease. Apparently slowing down aging is an appealing idea. So pick up your phone and Read This.